India's Wockhardt up on plans to shut down loss-making US business

** Shares of Wockhardt WCKH.NS rise 4.4% to 1,829.5 rupees, their highest in over 3 weeks

** Pharma co plans to shut down its loss-making US generic pharmaceutical segment in 15 months

** The shutdown is part of its US ops' realignment to focus on two segments - new antibiotic drug discovery, and biologicals portfolio in insulin

** Stock up 27.6% YTD